ELAN — Elanco Animal Health Inc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1739104 ·
Last close
$24.91
Market Cap
$12.44B
52W High
$26.37
52W Low
$19.40
ADV30
4,638,769
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,371,000,000 | 785,000,000 | 169,000,000 | 57,000,000 | 13,222,000,000 | 428,000,000 | 6,722,000,000 |
| Dec 2025 | 1,144,000,000 | 589,000,000 | 19,000,000 | -276,000,000 | 13,358,000,000 | 545,000,000 | 6,811,000,000 |
| Sep 2025 | 1,137,000,000 | 607,000,000 | 27,000,000 | -34,000,000 | 13,551,000,000 | 505,000,000 | 6,802,000,000 |
| Jun 2025 | 1,241,000,000 | 713,000,000 | 85,000,000 | 11,000,000 | 13,742,000,000 | 539,000,000 | 6,967,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$577,000,000
Investing CF
$-281,000,000
Financing CF
$-392,000,000
CapEx
$-262,000,000
Dividends Paid
—
Buybacks
$-47,000,000
EPS Diluted TTM
$-0.50
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,125,000,000
Inventory
$1,717,000,000
Receivables
$1,154,000,000
ST Investments
—
EBIT TTM
$40,000,000
Pretax Income TTM
$-197,000,000
Interest Exp TTM
$237,000,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,893,000,192
EBITDA
$970,000,000
Free Cash Flow
$692,124,992
Enterprise Value
$16,248,360,960
Total Cash
$428,000,000
Total Debt
$4,300,000,256
Shares Out
499,449,583
Trailing EPS
$-0.50
Book Value
$13.02
ROE
-3.8%
ROA
1.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,715,000,000 | 252,000,000 | -232,000,000 | 13,358,000,000 | 6,811,000,000 | — | 560,000,000 |
| Dec 2024 | 4,439,000,000 | 251,000,000 | 338,000,000 | 12,614,000,000 | 6,518,000,000 | — | 541,000,000 |
| Dec 2023 | 4,417,000,000 | 326,000,000 | -1,231,000,000 | 14,362,000,000 | 8,139,000,000 | — | 271,000,000 |
| Dec 2022 | 4,411,000,000 | 384,000,000 | -78,000,000 | 15,491,000,000 | 8,202,000,000 | — | 452,000,000 |
TTM Snapshot
Revenues TTM
$4,255,000,000
NetIncome TTM
$-901,000,000
OpCashFlow TTM
$0
Assets (Latest)
$12,614,000,000
Forward EPS
$1.20
Max Pain — expiry 2027-01-15
max pain strike: $20.00 · spot: $24.91 · call oi: 2,899 · put oi: 972
Expected Move to 2027-01-15:
±$7.40
(29.71%) —
implied range
$17.51 –
$32.31
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | $12.40B | $241.00 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $12.55B | $544.51 | — |
| AAVXF | Abivax S.A. | $12.12B | $139.00 | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $12.06B | $85.60 | — |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.47B | $59.33 | — |
News headlines (Yahoo Finance, 1h cache)
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great Choice
2026-07-22 16:00 · Yahoo
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plu
2026-07-22 10:27 · Yahoo
National Advertising Division Finds Certain PetIQ Claims Supported; Recommends Other Comparative Claims Be Modified or Discontinued
2026-07-16 14:21 · Yahoo
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
2026-07-15 16:10 · Yahoo
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
2026-07-08 12:00 · Yahoo
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?
2026-06-30 16:36 · Yahoo
Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches?
2026-06-25 12:42 · Yahoo
1 Mid-Cap Stock to Own for Decades and 2 We Question
2026-06-24 10:08 · Yahoo
BioHeartland Indiana Debuts at BIO 2026, Showcasing Indiana's Global Bioscience Leadership
2026-06-22 15:20 · Yahoo
Elanco To Launch Elanco Ventures With $25 Million Multi-Year Commitment To Accelerate Innovation in Animal Health
2026-06-19 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.